Breslin; Henry Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breslin; Henry Joseph.The latest application filed is for "ataxia telengiectasia and rad3-related (atr) protein kinase inhibitors".

Company Profile

2.13.14

Breslin; Henry Joseph - Lansdale PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use Grant 10,301,324 - Breslin , et al.	2019-05-28
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant 10,196,405 - Breslin , et al. Fe	2019-02-05
Ataxia Telengiectasia And Rad3-Related (ATR) Protein Kinase Inhibitors App 20180230168 - Breslin; Henry Joseph ; et al.	2018-08-16
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant 9,981,989 - Breslin , et al. May 29, 2	2018-05-29
Ataxia Telengiectasia And RAD3-Related (ATR) Inhibitors And Methods Of Their Use App 20170291911 - Breslin; Henry Joseph ; et al.	2017-10-12
Ataxia Telengiectasia And Rad3-Related (ATR) Protein Kinase Inhibitors App 20170226130 - Breslin; Henry Joseph ; et al.	2017-08-10
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant 9,663,535 - Breslin , et al. May 30, 2	2017-05-30
Ataxia Telengiectasia And Rad3-Related (ATR) Protein Kinase Inhibitors App 20160102104 - Breslin; Henry Joseph ; et al.	2016-04-14
Tripeptidyl peptidase inhibitors Grant 8,247,432 - Breslin , et al. August 21, 2	2012-08-21
Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors App 20120165519 - Ahmed; Gulzar ; et al.	2012-06-28
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors Grant 8,148,391 - Ahmed , et al. April 3, 2	2012-04-03
Tripeptidyl Peptidase Inhibitors App 20110224255 - Breslin; Henry Joseph ; et al.	2011-09-15
Tripeptidyl peptidase inhibitors Grant 7,947,713 - Breslin , et al. May 24, 2	2011-05-24
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors Grant 7,943,635 - Angibaud , et al. May 17, 2	2011-05-17
Triazoles as farnesyl transferase inhibitors Grant 7,592,356 - Saha , et al. September 22, 2	2009-09-22
FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS App 20090221555 - Ahmed; Gulzar ; et al.	2009-09-03
Triazoles as farnesyl transferase inhibitors Grant 7,511,061 - Saha , et al. March 31, 2	2009-03-31
Benzylimidazolyl Substituted 2-quinoline And Quinazoline Derivatives For Use As Farnesyl Transferase Inhibitors App 20080255191 - Angibaud; Patrick Rene ; et al.	2008-10-16
Tripeptidyl Peptidase Inhibitors App 20080108653 - Breslin; Henry Joseph ; et al.	2008-05-08
Triazoles as Farnesyl Transferase Inhibitors App 20080103150 - Saha; Ashis Kumar ; et al.	2008-05-01
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors Grant 7,241,777 - Angibaud , et al. July 10, 2	2007-07-10
Tripeptidyl peptidase inhibitors App 20060276509 - Breslin; Henry Joseph ; et al.	2006-12-07
Tripeptidyl peptidase inhibitors Grant 7,125,891 - Breslin , et al. October 24, 2	2006-10-24
Triazoles as farnesyl transferase inhibitors Grant 7,049,324 - Saha , et al. May 23, 2	2006-05-23
Triazoles as farnesyl transferase inhibitors App 20050234117 - Saha, Ashis Kumar ; et al.	2005-10-20
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors App 20050171111 - Angibaud, Patrick Rene ; et al.	2005-08-04
Tripeptidyl peptidase inhibitors App 20040034089 - Breslin, Henry Joseph ; et al.	2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.